Edgewise Therapeutics, Inc. (EWTX) vs Relay Therapeutics, Inc. (RLAY)
A side-by-side comparison of Edgewise Therapeutics, Inc. and Relay Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EWTX
Edgewise Therapeutics, Inc.
$40.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RLAY
Relay Therapeutics, Inc.
$18.74HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — EWTX vs RLAY
growth of $100 · dividends reinvested · last 6yEWTX +34.3% (+5.0%/yr)RLAY -45.5% (-9.6%/yr)EWTX compounded faster over this window
EWTX RLAY
EWTX vs RLAY: by the numbers
- •EWTX is the larger company ($4.31B vs $4.11B market cap).
- •Both run net losses; EWTX's is the smaller (0.00% vs -2763.64% net margin).
Metrics side by side
Valuation
| Metric | EWTX | RLAY |
|---|---|---|
| P/S ratio | N/A | 396.78 |
| P/B ratio | 9.61 | 4.61 |
Profitability
| Metric | EWTX | RLAY |
|---|---|---|
| Gross margin | 0.00% | 76.83% |
| Operating margin | 0.00% | -1971.59% |
| Net margin | 0.00% | -2763.64% |
| ROE | -44.02% | -32.14% |
| ROIC | -48.57% | -33.87% |
Growth (annualized)
| Metric | EWTX | RLAY |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -34.29% |
| Total return CAGR (5Y) | 16.95% | -7.92% |
Frequently asked
- How have EWTX and RLAY total returns compared?
- Over the past 5 years, EWTX delivered 16.95% and RLAY delivered -7.92% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.